EPL Presentations at the 2016 Society of Toxicologic Pathology (STP) Annual Meeting
0EPL is pleased to announce that our veterinary pathology staff will once again be associated with multiple presentations and scientific posters at the 2016 Society of Toxicologic Pathology (STP) Annual Meeting to be held in San Diego, CA from June 25-29, 2016. Oral Presentations Dr. …
Read More
A Further Look at Blind Slide Reading
In toxicologic pathology, “blind slide reading” involves procedures in which the pathologist is unaware of the treatment group status of individual animals during the histologic slide evaluation phase of a toxicologic bioassay. Blind slide reading continues to be a controversial topic, despite published recommendations on …
Read More-
EPL Pathologists to Participate in Pathology for Nonpathologists Course
Dr. Tom Steinbach and Dr. Peter Mann from EPL will be participating as speakers in the Pathology for Nonpathologists course, organized by the American College of Toxicology (ACT) and Society of Toxicology Pathology (STP). This course is offered every other year and will be held …
Read More -
EPL Pathologists Share Expertise at the 1st Southwest China Regional Toxicologic Pathology Workshop/Slide-Reading Seminar
On March 4, 2016, Dr. Peter Mann and Dr. Paul Snyder from EPL participated in the 1st Southwest China Regional Toxicologic Pathology Workshop/Slide-Reading Seminar. Dr. Mann and Dr. Snyder organized and developed the seminar to provide education for Asian Toxicologists and Pathologists on study design …
Read More -
EPL, Inc. Opens a Northeast Office in Collegeville, Pennsylvania
Experimental Pathology Laboratories, Inc. (EPL®) established EPL Northeast on February 8, 2016. This office is headed by Dr. Heath Thomas who was formerly Vice President of Safety Assessment at GlaxoSmithKline. The Northeast office is located outside of Philadelphia at 125 Chinaberry Lane, Collegeville, PA. With …
Read More 
EPL Participates in SETAC Pellston Workshop for Risk Assessment Approaches for Endocrine-Active Chemicals
Dr. Jeff Wolf, EPL CSO and Manager of Pathology at the Virginia Laboratory, participated in a SETAC-Pellston Workshop™ entitled “”Environmental Hazard and Risk Assessment Approaches for Endocrine-Active Chemicals (EHRA): Developing Technical Guidance based on case studies to Support Decision Making.” The workshop was held in …
Read More
EPL Activities at the 55th Annual Meeting of the Society of Toxicology (SOT)
EPL will once again be exhibiting at ToxExpo™ in New Orleans from March 14-16, 2016. If you are attending the 55th Annual Society of Toxicology Meeting, please visit our team; we will be exhibiting in Booth #1319. Dr. Gabrielle is an author of the poster, …
Read More
Meet Aclairo Pharmaceutical Development Group
Imagine a group of great scientists and all around nice folks who worked with another group for years in dovetailed projects for their clients. It does not take much imagination to wonder why these folks would want to be in one happy group together. On …
Read More
Experimental Pathology Laboratories, Inc. (EPL) Acquires Aclairo Pharmaceutical Development Group, Inc.
EPL and Aclairo Combine Preclinical Services Expertise EPL is pleased to announce that it has acquired Aclairo Pharmaceutical Development Group, Inc. (Aclairo) which provides independent and objective nonclinical, regulatory, and clinical ADME/DMPK expert strategy and implementation to the pharmaceutical and drug device industries. “Aclairo’s team …
Read More-
2015: Year in Review
It certainly was an eventful year at Experimental Pathology Laboratories, Inc. (EPL) again in 2015! Here’s what you may have missed………. EPL continues to add expertise in pathology by establishing a California site headed by Dr. Ted Birkebak in the San Francisco Bay Area to …
Read More
